
IGF-1 LR3 1mg arrived with clear documentation, intact packaging and a batch-specific COA that made internal receipt checks straightforward.

For research use only. Not for human or animal consumption.
BPC-157 + TB-500 is a dual-peptide research formulation designed for laboratory investigation into peptide signalling pathways, cellular communication mechanisms, and regulatory peptide interactions.
This blend combines:
Both peptides are widely referenced in experimental peptide research environments focused on intracellular signalling systems and peptide-mediated regulatory processes.
Supplied as a high-purity lyophilised research blend, this formulation is intended strictly for controlled laboratory applications.
Within experimental laboratory environments, BPC-157 and TB-500 are commonly investigated for their interaction with:
The combination allows researchers to study comparative peptide behaviour and multi-pathway peptide interaction models within controlled research settings.
BPC-157 is a synthetic peptide derived from peptide fragments originally identified during gastric peptide research investigations. In laboratory environments, it is frequently explored in peptide signalling and molecular interaction studies.
TB-500 is a synthetic peptide sequence associated with thymosin beta-4 research models. It is commonly studied in experimental settings focused on cellular regulatory systems and peptide-mediated signalling behaviour.
The BPC-157 + TB-500 combination is frequently referenced in experimental peptide research examining:
Each batch undergoes analytical verification to confirm:
COA documentation is available where applicable.
Total peptide content: 20mg
This product is intended strictly for laboratory and scientific research purposes only.
BPC-157 + TB-500 remains a frequently referenced peptide combination in experimental peptide research due to its dual-peptide composition and compatibility with controlled signalling pathway investigations.
Its combined structure allows researchers to explore peptide interaction behaviour, comparative signalling activity, and intracellular regulatory mechanisms within standardized laboratory environments.

IGF-1 LR3 1mg arrived with clear documentation, intact packaging and a batch-specific COA that made internal receipt checks straightforward.

AOD 9604 5mg was dispatched quickly and the labeling was precise. The published test data matched what our team expected from a research supplier.

AOD 9604 10mg was easy to verify against the listed batch information. Clean presentation, responsive support and smooth EU delivery.

Thymosin Alpha 1 10mg came with the level of traceability we need. The online certificate and packaging consistency were both very good.

Thymosin Alpha 1 Nasal Spray 10mg was packed securely and delivered on time. Useful product page details and a professional overall process.

GLOW 70mg pen order was handled efficiently and the quality paperwork was easy to review before purchase.

Selank Nasal Spray 10mg arrived with clear instructions and careful packing. The experience felt well organized from checkout to delivery.

Semax Nasal Spray 10mg was exactly as described. Strong communication, fast processing and transparent product documentation.

Our Berlin team ordered IGF-1 LR3 1mg and the process was excellent from checkout to delivery. The batch data was easy to review and the packaging arrived in very professional condition.
For research use only. Not for human or animal consumption.
BPC-157 + TB-500 is a dual-peptide research formulation designed for laboratory investigation into peptide signalling pathways, cellular communication mechanisms, and regulatory peptide interactions.
This blend combines:
Both peptides are widely referenced in experimental peptide research environments focused on intracellular signalling systems and peptide-mediated regulatory processes.
Supplied as a high-purity lyophilised research blend, this formulation is intended strictly for controlled laboratory applications.
Within experimental laboratory environments, BPC-157 and TB-500 are commonly investigated for their interaction with:
The combination allows researchers to study comparative peptide behaviour and multi-pathway peptide interaction models within controlled research settings.
BPC-157 is a synthetic peptide derived from peptide fragments originally identified during gastric peptide research investigations. In laboratory environments, it is frequently explored in peptide signalling and molecular interaction studies.
TB-500 is a synthetic peptide sequence associated with thymosin beta-4 research models. It is commonly studied in experimental settings focused on cellular regulatory systems and peptide-mediated signalling behaviour.
The BPC-157 + TB-500 combination is frequently referenced in experimental peptide research examining:
Each batch undergoes analytical verification to confirm:
COA documentation is available where applicable.
Total peptide content: 20mg
This product is intended strictly for laboratory and scientific research purposes only.
BPC-157 + TB-500 remains a frequently referenced peptide combination in experimental peptide research due to its dual-peptide composition and compatibility with controlled signalling pathway investigations.
Its combined structure allows researchers to explore peptide interaction behaviour, comparative signalling activity, and intracellular regulatory mechanisms within standardized laboratory environments.
109.99 €
Orders are shipped in plain, unbranded outer packaging with no product names or contents shown on the parcel.
4.7 out of 5 based on 60 reviews
See what customers say about Research Peptides Europe.
View All Reviews
{Research Peptides Europe}
Typically replies within minutes
Thanks for contacting Research Peptides Europe
How can we help you today ?
WhatsApp Us
🟢 Online | Privacy policy
WhatsApp us